Investigations on the molecular dosimetry of tobacco-specific N-nitrosamines

Area of Science:

• Toxicology
• Biomarkers
• Carcinogenesis

Background:

• Tobacco-specific nitrosamines, including 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN), are potent carcinogens.
• Assessing human exposure and metabolic activation of these compounds is crucial for understanding tobacco-related cancer risks.
• Molecular dosimetry using adducts provides a sensitive method to quantify exposure and biological effects.

Purpose of the Study:

• To discuss approaches for molecular dosimetry of NNK and NNN in humans.
• To evaluate the utility of hemoglobin and DNA adducts as biomarkers of exposure.
• To explore methods for detecting specific adducts in vivo.

Main Methods:

• Measurement of hemoglobin adducts (e.g., 4-hydroxy-1-(3-pyridyl)-1-butanone) after hydrolysis of globin.
• Analysis of DNA methylation adducts (e.g., O6-methyldeoxyguanosine) using immunoassays.
• Development of 32P-postlabeling assays for pyridyloxobutyl DNA adducts.

Main Results:

• Hemoglobin adducts were detected in rats up to six weeks after NNK injection, suggesting their potential as markers.
• NNK and its metabolite NNAI methylated DNA in various rat tissues.
• Immunoassays for O6-medGuo in human oral cells were negative, indicating limited utility for this specific adduct.

Conclusions:

• Hemoglobin adducts may serve as useful markers for assessing NNK and NNN uptake and activation in tobacco consumers.
• 32P-postlabeling assays show promise for detecting NNK/NNN-DNA adducts in vivo.
• Further development of sensitive analytical methods is needed for accurate molecular dosimetry.